(Q56240933)

English

EGFR L861

genetic variant

L861

In more languages

default for all languages

No label defined

No description defined

Statements

biological variant of

1 reference

28 March 2022

https://civic.genome.wustl.edu/links/variants/1866

positive therapeutic predictor for

determination method or standard

CIViC evidence level B

CIViC 3-star trust rating

medical condition treated

non-small-cell lung carcinoma

1 reference

28 March 2022

https://civic.genome.wustl.edu/links/evidence/4298

Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer.

determination method or standard

CIViC evidence level B

CIViC 3-star trust rating

medical condition treated

non-small-cell lung carcinoma

1 reference

28 March 2022

https://civic.genome.wustl.edu/links/evidence/4298

Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer.

Identifiers

CIViC variant ID

1 reference

28 March 2022

https://civic.genome.wustl.edu/links/variants/1866

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56240933&oldid=2014811112"